"How do I cope with the anxiety of a cancer diagnosis?"

The anxiety that follows a cancer diagnosis is recognised in the clinical literature, well documented, and has a measurable shape. The most-studied form is what is called fear of cancer recurrence (FCR), defined in the clinical-consensus literature as fear, worry, or concern relating to the possibility that cancer will come back or progress (Lebel et al., 2016). FCR sits between two extremes: a passing thought that does not affect daily life, and a clinically significant pattern that does. The middle ground is where most people are, and it shifts over time.

Written and reviewed by Matthew Hallam, Registered Psychologist (AHPRA PSY0002471369). 3 min read. Published 7 June 2026. Last reviewed 7 June 2026. Next review 7 June 2027.

Need help right now? Crisis 000 · Lifeline 13 11 14 · Beyond Blue 1300 22 4636 · Suicide Call Back 1300 659 467

How common it is

A 2022 combined study of research findings by Luigjes-Huizer and colleagues, drawing on individual patient data from 46 studies across 13 countries, found that around 3 in 5 cancer survivors scored at moderate-to-high levels on validated measures of fear of cancer recurrence (Luigjes-Huizer et al., 2022). The figure does not vary substantially by cancer type, though it is influenced by stage, time since diagnosis, and age at diagnosis. Younger people, on average, score higher.

For blood cancers specifically, an Australian population-registry study by Hall and colleagues found that around 1 in 4 haematological cancer survivors reported above-normal levels of anxiety and depression (Hall et al., 2016). A 2023 study of research findings by Tan, Talaulikar, and Scholz at the Australian National University on lymphoma identified consistent risk factors for emotional distress: younger age, relapse, comorbid conditions, and high symptom burden (Tan et al., 2023).

What the literature distinguishes

The clinical literature draws a useful distinction. Fear of cancer recurrence is the worry about the future of the illness. It is not the same as the broader distress that follows a diagnosis, and it is not the same as anxiety or depression as standalone conditions, though it overlaps with both. The distinction matters because the work on FCR is now well developed in the psycho-oncology literature, and is recognisable as a distinct kind of work.

What FCR responds to, in the research, is not reassurance. Reassurance reduces the anxiety briefly and increases it over time, because the search for reassurance becomes part of the loop. What it does respond to is what the literature calls accommodation of uncertainty: the capacity to live with an unknown future without requiring it to be known. This is harder to learn than it sounds. It is also, in the research, learnable.

A GP review is appropriate when the worry is interrupting sleep, when it is affecting day-to-day function, when it is driving repeated reassurance-seeking that does not settle, or when it is accompanied by low mood, hopelessness, or thoughts you would not want to share. The site-wide crisis resources are the right pathway for anything more urgent. The worry has a recognisable shape, has been studied, and is amenable to a specific kind of work that is different from the work for generalised anxiety. For people living with cancer or in the period after treatment, naming what is being experienced is often the first step in working with it, rather than being worked on by it. The companion guide on the illness-anxiety loop develops the broader mechanism this sits inside.

This content is general information only. It is not a substitute for individual psychological or medical advice. Reading this does not establish a therapeutic relationship with Equal Psychology or any of their clinicians.